Feb 13 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2017 Dec 31, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 12.92 11.47 17.50
(+12.7 pct) (+12.3 pct) (+8.5 pct)
Operating 1.51 1.03 1.90
(+45.8 pct) (+134.2 pct) (+7.4 pct)
Recurring 1.50 1.01 1.88
(+47.8 pct) (+119.0 pct) (+7.5 pct)
Net 982 mln 647 mln 1.30
(+51.7 pct) (+96.4 pct) (+7.1 pct)
EPS 249.69 yen 164.63 yen 330.48 yen
Ann Div 30.00 yen 30.00 yen
-Q2 div NIL NIL
-Q4 div 30.00 yen 30.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T
((Tokyo Headline News Desk +813 6441 1812))